Masuda Takafumi, Katakami Naoto, Taya Naohiro, Miyashita Kazuyuki, Takahara Mitsuyoshi, Kato Ken, Shimomura Iichiro
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
J Diabetes Investig. 2025 Sep;16(9):1653-1662. doi: 10.1111/jdi.70108. Epub 2025 Jul 2.
Despite the increasing number of studies using machine learning to develop individualized treatment strategies, only a few have been conducted in patients with type 1 diabetes. This study aimed to identify the characteristics of Japanese patients with type 1 diabetes, classified into subgroups using data-driven cluster analysis based on pancreatic beta-cell function, obesity, and glycemic control, and clarify the association between these subgroups and diabetic complications.
In this cross-sectional study, a cluster analysis using three variables (C-peptide, body mass index, and glycated hemoglobin) in 206 Japanese patients with type 1 diabetes was performed. Multivariate logistic regression analysis was performed to compare the risk of diabetic complications by subgroup.
The cluster analysis identified four subgroups. Group 2 (n = 58), characterized by high body mass index levels, had a higher risk of hepatic steatosis than the control group (Group 1, n = 90). Meanwhile, Group 3 (n = 44), characterized by high glycated hemoglobin levels, had higher risks of retinopathy, polyneuropathy, elevated brachial-ankle pulse wave velocity, and hepatic steatosis than Group 1 and Group 4 (n = 14), characterized by residual endogenous insulin, had a higher risk of chronic kidney disease than Group 1.
The risks of diabetic complications differed between subgroups of Japanese patients with type 1 diabetes. Tailored treatment approaches based on subgroup characteristics are a potential treatment option for reducing the risks of diabetic complications in this population.
尽管使用机器学习制定个体化治疗策略的研究数量不断增加,但在1型糖尿病患者中开展的此类研究却为数不多。本研究旨在确定日本1型糖尿病患者的特征,基于胰腺β细胞功能、肥胖和血糖控制情况,采用数据驱动的聚类分析将患者分为不同亚组,并阐明这些亚组与糖尿病并发症之间的关联。
在这项横断面研究中,对206例日本1型糖尿病患者使用三个变量(C肽、体重指数和糖化血红蛋白)进行聚类分析。采用多因素逻辑回归分析比较各亚组糖尿病并发症的风险。
聚类分析确定了四个亚组。第2组(n = 58)以高体重指数水平为特征,其发生肝脂肪变性的风险高于对照组(第1组,n = 90)。同时,第3组(n = 44)以高糖化血红蛋白水平为特征,其发生视网膜病变、多发性神经病变、臂踝脉搏波速度升高和肝脂肪变性的风险高于第1组;第4组(n = 14)以残余内源性胰岛素为特征,其发生慢性肾脏病的风险高于第1组。
日本1型糖尿病患者各亚组的糖尿病并发症风险存在差异。基于亚组特征的个体化治疗方法是降低该人群糖尿病并发症风险的一种潜在治疗选择。